Consumer Health & Nutrition

Drug Delivery & Devices

PharmaVision's Drug Delivery and Device reports analyze the impact of advanced drug delivery systems and devices on approved and new products to optimize product life cycle management and reposition products. Increasingly the pharmaceutical industry utilizes novel formulations and delivery platforms earlier in the development process to overcome solubility and toxicities issues and improve biodistribution, pharmacokinetics and ease of use. In addition, generic and biogeneric manufacturers are applying advanced delivery technologies to differentiate their products to increase their foothold in the market. Each report analyzes key market trends, therapeutic developments and market leaders and provides detailed market forecasts for products and/or technologies.

Drug Delivery & Devices Research Reports

GE Healthcare - SWOT, Strategy and Corporate Finance Report

Published: 03/10/2012

GE ML 031012

Medtronic, Inc.: The journey from electrical repair

Published: 25/09/2012

ML00007-017

Innovations in Drug Delivery

Published: 11/09/2012

GBIHC261MR

Medtronic, Inc

Published: 21/02/2012

DM Med 0212

Depomed, Inc

Published: 04/11/2011

DMDEPO 1111

Emerging Drug Delivery Technologies & Strategies: Players, Pipelines & Partnerships

Published: 12/09/2011

ESPDDPPP

Angiotech Pharmaceuticals, Inc.

Published: 14/06/2011

DM AngP 0611

Antares Pharma, Inc.

Published: 14/06/2011

DM AntP 0611

Dr. Reddys Laboratories Ltd

Published: 14/06/2011

DM DrR 0611

Endo Pharmaceuticals Holdings Inc.

Published: 14/06/2011

DM Endo 0611

Apotex, Inc

Published: 05/06/2011

Dm Apo 0611

Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015

Published: 30/01/2011

ESP OR & PR DD 01/11

Drug Delivery: Surveying the Global Competitive Landscape

Published: 31/12/2010

ESP DD GLOBAL 12/10

Novel Antibodies & Therapeutic Proteins: Technological Challenges

Published: 04/08/2010

PV AB & TP 08/10

Advances in Vaccine Technology & Delivery

Published: 13/01/2010

ESP VAC DD 01/10

Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities

Published: 01/07/2009

PV RNAI DD 07/09

Drug Delivery Technologies: Nucleic Acid Delivery

Published: 26/06/2009

ESP DD NA 06/09

Drug Delivery Technologies: Controlled-release

Published: 26/06/2009

ESP DD CR 06/09

Drug Delivery Technologies: Targeted Delivery

Published: 26/06/2009

ESP DD TD 06/09

Drug Delivery Technologies: Nano-enabled Delivery

Published: 26/06/2009

ESP DD NANO 06/09

Delivering New Biopharmaceutical Therapies: Challenges & Opportunities

Published: 19/01/2009

PV BIOPHAMA 01/09

Stem Cell-Based Therapeutic Delivery: Challenges & Opportunities

Published: 15/12/2008

PV SC DD 12/08

Drug Delivery Technology: Revolutionizing CNS Therapies

Published: 13/12/2007

PV DD CNS 12/07

Drug Delivery Technology: Developing a New Generation of Vaccines

Published: 23/11/2007

PV DD VAC 11/07

Drug Delivery Technology: Revolutionizing Diabetes Treatment

Published: 20/09/2007

PV DD DIA 09/07

Drug Delivery Technology: Revolutionizing Cardiovascular Therapies

Published: 09/07/2007

PV DD CV 07/07

Drug Delivery Technology: Revolutionizing Cancer Therapies

Published: 01/05/2007

PV DD CAN 05/07